| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 07/10/2021 | 32010BD P. GERAL* | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 39 | 137 | 0 | 1 | 0 | 199 |
| 07/10/2021 | 210460 P. GERAL | Butantan/CoronaVac | 7 | 3 | 0 | 0 | 0 | 10 |
| 14/10/2021 | 219VCD273Z P. GERAL | Fiocruz/Oxford/AstraZeneca | 5 | 15 | 1 | 0 | 0 | 21 |
| 14/10/2021 | 32010BD P. GERAL* | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 6 |
| 14/10/2021 | 210478 P. GERAL | Butantan/CoronaVac | 100 | 270 | 0 | 0 | 0 | 370 |
| 19/10/2021 | FH8023 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 38 | 142 | 0 | 0 | 0 | 198 |
| 25/10/2021 | FH4750 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 97 | 348 | 0 | 0 | 0 | 492 |
| 28/10/2021 | FJ2594 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 30 | 201 | 0 | 0 | 0 | 252 |
| 11/11/2021 | 210480 P. GERAL | Butantan/CoronaVac | 8 | 2 | 0 | 0 | 0 | 10 |
| 11/11/2021 | 219VCD273Z P. GERAL | Fiocruz/Oxford/AstraZeneca | 0 | 20 | 0 | 1 | 0 | 21 |
| 12/11/2021 | FH4750 P.GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 56 | 206 | 4 | 0 | 0 | 304 |
| 17/11/2021 | FJ2594 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 144 | 244 | 0 | 0 | 0 | 504 |
| 19/11/2021 | FJ2594 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 119 | 341 | 0 | 0 | 0 | 504 |
| 19/11/2021 | 219VCD285W P.GERAL | Fiocruz/Oxford/AstraZeneca | 40 | 220 | 0 | 0 | 0 | 300 |
| 22/11/2021 | 219VCD285W P. GERAL | Fiocruz/Oxford/AstraZeneca | 70 | 185 | 0 | 0 | 0 | 255 |
| 24/11/2021 | FK0596 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 125 | 286 | 0 | 0 | 0 | 504 |
| 25/11/2021 | FL5729 - IDOSOS E T. SAUDE | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 190 | 403 | 0 | 0 | 0 | 684 |
| 02/12/2021 | FM3355 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 176 | 528 | 0 | 0 | 0 | 800 |
| 07/12/2021 | FL5729 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 120 | 289 | 0 | 0 | 0 | 504 |
| 14/12/2021 | FL4222 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 177 | 300 | 0 | 0 | 0 | 1.002 |
| 14/12/2021 | 1855836 P. GERAL | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 85 |
| 14/12/2021 | FM3355 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 42 | 103 | 0 | 0 | 0 | 300 |
| 14/12/2021 | FL5729 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 20 | 20 | 0 | 0 | 0 | 84 |
| 20/12/2021 | 204H21A P. GERAL | Janssen Covid-19 Vaccine | 1 | 328 | 0 | 0 | 0 | 395 |
| 27/12/2021 | FM3457 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 100 | 270 | 0 | 0 | 0 | 810 |
| 07/01/2022 | FM3457 P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 190 | 187 | 0 | 0 | 0 | 1.110 |
| 14/01/2022 | FP1176 - PEDIÁTRICA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 40 | 0 | 0 | 0 | 0 | 40 |
| 17/01/2022 | FL3202 - P. GERAL | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 73 | 174 | 0 | 0 | 0 | 672 |
| 17/01/2022 | 209F21A - P. GERAL | Janssen Covid-19 Vaccine | 5 | 0 | 0 | 0 | 0 | 220 |
| 20/01/2022 | FP8290 - PEDIÁTRICA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 40 | 0 | 0 | 0 | 0 | 40 |
